Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2016, vol. 25, nr 1, January-February, p. 129–133

doi: 10.17219/acem/32629

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Evaluation of Soft Tissue Reaction to Corundum Ceramic Implants Infiltrated with Colloidal Silver

Witold Wnukiewicz1,A,B,C,D,F, Roman Rutowski2,A,C, Beata Zboromirska-Wnukiewicz3,A,B,C, Paweł Reichert1,C,E, Jerzy Gosk1,C,D,E,F

1 Department of Traumatology, Clinic of Traumatology and Hand Surgery, Wroclaw Medical University, Poland

2 Department of Sport Medicine, The University School of Physical Education, Wrocław, Poland

3 Department of Ceramics and Bioplastics, Institute of Electrical Engineering, Wrocław, Poland

Abstract

Background. Corundum ceramic is a biomaterial used as a bone graft substitute. Silver is a well known antiseptic substance with many practical, clinical applications.
Objectives. The aim of this study was to estimate soft tissue (in vivo) reaction to a new kind of ceramic implants. In our experiment, we examined the soft tissue reaction after implantation of corundum ceramic infiltrated with colloidal silver in the back muscles of 18 Wistar rats. The use of colloidal silver as a coating for the implant was designed to protect it against colonization by bacteria and the formation of bacterial biofilm.
Material and Methods. In our study, based on the experimental method, we performed implantation operations on 18 Wistar rats. We implanted 18 modified ceramic implants and, as a control group, 18 unmodified implants. As a follow up, we observed the animals operated upon, and did postoperative, autopsy and histopathological examinations 14, 30, 90 and 180 days after implantation.
Results. We didn’t observe any pathological reactions and significant differences between the soft tissue reaction to the modified implants and the control group.
Conclusion. Lack of pathological reaction to the modified implants in the living organism is the proof of their biocompatibility. This is, of course, the first step on the long path to introduce a new kind of biocompatible ceramic implant with antiseptic cottage. Our experiment has an only introductory character and we plan to perform other, more specific, tests of this new kind of implant.

Key words

biomaterials, corundum ceramic, colloidal silver, implants

References (21)

  1. Bieniek J, Święcicki Z, Rosiek G, Badura R, Kotz J, Buczek A: Właściwości i zastosowanie kliniczne porowatej ceramiki korundowej. SiC 1998, 49, 2–5.
  2. Burd TA: In vitro evaluation of tobramycin from bioabsorbable polycaprolactone beads. J Orthop Trauma 2001, 15, 424–428.
  3. Calhoun JH, Mader JT: Treatment of osteomyelitis with biodegradable antibiotic implant. Clin Orthop Related Res 1997, 341, 206–214.
  4. Ewald A, Glűckermann S, Thull R, Gbureck U: Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng Online 2006, 5–22.
  5. Garvin KL: Polyactide/polyglycolide antibiotic implants in the treatment of osteomyelitis – a canine model. J Bone Joint Surg 1994, 76-A, 1500–1506.
  6. Guzman M, Dille J, Godet S: Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine 2012, 8, 37–45.
  7. Harms J, Mäusle E: Tissue reaction to ceramic implant material. J Biomed Mater Res 1979, 13, 67–87.
  8. Jaegermann Z, Ślósarczyk A: Gęsta i porowata bioceramika korundowa w zastosowaniach medycznych. Uczelniane Wydawnictwa Naukowo-Dydaktyczne AGH, Kraków 2007.
  9. Kanellakopoulou K: Lactic acid polymers as biodegradable carriers of fluoroquinolones: An in vitro study. Antimicrob Ag Chemother 1999, 43, 714–716.
  10. Klemm KW: Gentamicin-PMMA chains (septopal chains) for the local treatment of chronic osteomyelitis. Reconstr Surg Traumatol 1988, 20, 11–35.
  11. Wanabe K: Treatment of osteomyelitis by antibiotic-soaked porous glass ceramic. J Bone Joint Surg 1998, 80-B, 527–530.
  12. Mack D: Molecular mechanisms of Staphylococcus epidermidis biofilm formation. J Hosp Infect 1999, 43, 113–125.
  13. Mack D, Rohde H, Harris LG, Davies AP, Horstkotte MA, Knobloch JK: Biofilm formation in medical devicerelated infection. Int J Artif Organs 2006, 29, 343–359.
  14. Liu SJ: In vitro evaluation of vancomycin from biodegradable beads. J Biomed Mater Res 1999, 48, 613–620.
  15. Mader JT: In vitro evaluation of antibiotic diffusion from antibiotic-impregnated beads and polymethylmetacrylate beads. Antimicrob Ag Chemother 1997, 41, 415–418.
  16. Nicolau DP: Prophylaxis of acute osteomyelitis with absorbable ofloxacin-impregnated beads. Antimicrob Ag Chemother 1998, 42, 840–842.
  17. Price JS: Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 1996, 30, 281–286.
  18. Rusiecki M, Pielka S, Paluch D, Staniszewska-Kuś J, Solski L: Wpływ kompozytu korundowego na odczyn tkanek miękkich. Polim Med 2004, 34.
  19. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD: The efficacy of silver alloy-coated urinary catherers in preventing urinary tract infection: meta-analysis. Am J Med 1998, 105, 236–241.
  20. Samberg M, Orndorff P, Monteiro-Riviere N: Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 2011, 5, 244–253.
  21. Wnukiewicz W: Badania biologiczne implantów z ceramiki korundowej infiltrowanej srebrem koloidalnym. Praca doktorska AM, Wrocław 2010.
© Wroclaw Medical University